BigHat

BigHat

Private
San Mateo, CaliforniaHealthcare & Life Scienceshttps://www.bighatbio.com

Last Round

Series B

Apr 28, 2025

Est. Valuation

$304.1M

Total Funding Raised

$223.5M

Company Overview

BigHat Biosciences is a biotechnology company that offers an innovative platform for developing biological antibodies and therapeutic proteins through the integration of wet laboratory techniques with artificial intelligence and machine learning.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

antibody engineeringAI drug discoveryantibody designdrug discovery platformgenerative biologymachine learning for drug discoverybiologics discoveryprotein therapeuticsbispecific antibodiesantibody-drug conjugatesADCswet lab integrationprotein engineeringT-cell engagerssynthetic biologybiopharma partnerships

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BigHat Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BigHat Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BApr 28, 2025
Series BJul 20, 2022
Series AFeb 10, 2021
GrantNov 1, 2020
SeedDec 19, 2019

Key People

Founding team and executive leadership

Peyton Greenside

Founder And CSO, CEO, President

Founding Team

BigHat Investors

Notable investors and investment history

InvestorRounds
Andreessen HorowitzSeries B, Series A
S32Series B
Innovation EndeavorsSeries A, Seed
GaingelsSeries B
M VenturesSeries B, Series A
Quain InvestmentsSeries B
National Institute of Standards and TechnologyGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 28, 2025

    $124M round raised at $304M post-money valuation.

  • Jul 20, 2022

    $75M Series B round completed.

BigHat Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BigHat Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BigHat's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Mateo, California
Employee Range97
Year Founded2019
Last FundingApr 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.